This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Juxtaposing zero-based with monthly budgeting highlights where each excels, aiding you in selecting a method that fits your life and income cadence.
28,655 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
SVB Capital, a 110-person venture arm once tied to SVB Bank, is in limbo after regulators seized the parent bank. A p...
Five years into Citi CEO Jane Fraser’s tenure, a sweeping rebuild has shifted the bank from risk and tech bottlenecks...
A new wave of policy and investment is aimed at loosening China’s grip on rare earth processing. Yet the bottleneck i...
Taiwan enacted a comprehensive stablecoin framework on June 30, 2025, mandating full reserves, domestic custody, and ...
When markets swing on news and surprises, traders crave flexibility. The cboe global markets launch of extended hours...
FMC stock has seen a sharp drop, prompting questions about value and timing. This guide breaks down how to tell if th...
The House narrowly rejected a war-powers measure aimed at stopping Iran strikes, a sign of growing concern about cost...
A fast-growing tech name in the AI space has dazzled investors, but a recent funding move underscored a crucial risk....
A California family filed a wrongful-death lawsuit against OpenAI, claiming ChatGPT guidance led to a teen's fatal ov...
Michigan Governor Gretchen Whitmer backtracked on an earlier line about a 2028 presidential bid, saying she had nothi...
A scammer used a fake online romance to drain a senior’s savings, underscoring urgent fraud risks for older adults. L...